XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 29, 2023
Jul. 30, 2022
Jul. 29, 2023
Jul. 30, 2022
Jan. 28, 2023
Derivative Instruments, Gain (Loss) [Line Items]          
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net [1] $ (1,708) $ 4,124 $ (2,614) $ 7,809  
Length of time inventory sales hedged (in months)     12 months    
Euro Member Countries, Euro          
Derivative Instruments, Gain (Loss) [Line Items]          
Notional Amount [2] 80,554   $ 80,554    
United Kingdom, Pounds          
Derivative Instruments, Gain (Loss) [Line Items]          
Notional Amount [2] 67,170   67,170    
Canada, Dollars          
Derivative Instruments, Gain (Loss) [Line Items]          
Notional Amount [2] 27,760   27,760    
Fair Value, Recurring [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Other current assets [3] 536   536   $ 32
Accrued expenses 2,312   2,312   4,986
Level 2 | Fair Value, Recurring [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Other current assets 536   536   32 [3]
Accrued expenses $ 2,312   $ 2,312   $ 4,986
[1] Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.
[2] Amounts reported are the U.S. Dollar notional amounts outstanding as of July 29, 2023.
[3] (2)    Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts.